Tom van de Wijngaart

Research Associate, Structural Biology at Ambagon Therapeutics

No bio yet

Location

Eindhoven, Netherlands

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Ambagon Therapeutics

Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.